Brentwood Bay, Canada

Clive T R Burge

This inventor holds 5 USPTO granted patents and 1 EPO patent. Top assignees: The University of Texas System, Hana Biosciences, Inc., Inex Pharmaceuticals Corporation. Active years: 2004-2011.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Clive T R Burge. Retrieved from https://idiyas.com/inventor/clive-t-r-burge

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 80.0

 

Average Co-Inventor Count = 6.5

ph-index = 3

Forward Citations = 39(Granted Patents)


Company Filing History:


Years Active: 2004-2011

Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

Title: The Innovative Mind of Clive T R Burge

Introduction

Clive T R Burge is a notable inventor based in Brentwood Bay, CA, recognized for his significant contributions to the field of oncology through his innovative patents. With a total of five patents under his name, Burge has focused primarily on developing methods and compositions for treating various forms of cancer, particularly lymphomas. His work exemplifies the intersection of science and technology in addressing challenging medical conditions.

Latest Patents

Among Burge's latest patents, two stand out for their potential impact on cancer treatment. The first, titled "Compositions and methods for treating lymphoma," revolves around administering liposome-encapsulated vinca alkaloids, such as vincristine, to mammals afflicted with lymphomas, including relapsed forms of Non-Hodgkin's Lymphoma. This patent outlines innovative methods aimed at enhancing therapeutic effectiveness while minimizing side effects. The second patent, "Compositions and methods for treating cancer," offers a similar approach, utilizing liposome-encapsulated vinca alkaloids, such as vinorelbine, to treat neoplasias in mammals. These advancements highlight Burge's commitment to improving cancer treatment methodologies.

Career Highlights

Throughout his career, Clive T R Burge has made considerable strides in pharmaceutical research and development. He has worked with esteemed institutions, including the University of Texas System, where he contributed to cutting-edge research projects. Additionally, his tenure at Inex Pharmaceuticals Corporation allowed him to collaborate on various innovative solutions aimed at advancing cancer therapies.

Collaborations

Burge's journey as an inventor has also been marked by fruitful collaborations with other experts in the field. He has worked alongside renowned colleagues such as Andreas H Sarris and Fernando Cabanillas, pooling their knowledge and expertise to drive innovations in cancer treatment. These partnerships demonstrate the importance of collaboration in scientific advancements and the development of effective therapies.

Conclusion

Clive T R Burge's contributions to the field of oncology through his patents represent a significant step forward in the fight against cancer. His innovative methodologies and compositions aimed at treating various forms of lymphoma and other neoplasias reflect his dedication to improving patient outcomes. As research in this area continues to evolve, Burge's work serves as an inspiring example of how inventors can impact healthcare through innovation.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…